---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-26-008772"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2026-07-21T20:30:22+00:00"
generated_at: "2026-07-21T20:31:37.244272+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro announces death of director Lynne Fahey McGrath on July 20, 2026

## Summary
- Dr. Lynne Fahey McGrath, a director of Alzamend Neuro, passed away on July 20, 2026.
- She served on the Board since the company's IPO in June 2021.
- Chairman William B. Horne expressed condolences and highlighted her contributions and insights.

## SEC filing metadata
- accession: 0001214659-26-008772
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2026-07-21T20:30:22+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465926008772/0001214659-26-008772-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465926008772/p7202618k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-26-008772
- JSON: https://secwatch.observer/filing/0001214659-26-008772.json
- Plain text: https://secwatch.observer/filing/0001214659-26-008772.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.